首页>
外国专利>
PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH HYPOGLYCEMIC ACTION, ON THE BASIS OF 1,3-DIG SUBSTITUTED-2-IMINO-IMIDAZOLIDINE DERIVATIVES, THE PREPARED PREPARED PREPARATORY PREPARATIONS, AND PREPARED IN PROCESSED PROPERTIES , 3-DUBSTITUTED -2-IMINO-IMIDAZOLIDINE DERIVATIVES.
PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH HYPOGLYCEMIC ACTION, ON THE BASIS OF 1,3-DIG SUBSTITUTED-2-IMINO-IMIDAZOLIDINE DERIVATIVES, THE PREPARED PREPARED PREPARATORY PREPARATIONS, AND PREPARED IN PROCESSED PROPERTIES , 3-DUBSTITUTED -2-IMINO-IMIDAZOLIDINE DERIVATIVES.
1306602 Acylamino- and thioacylaminoalkyl - phenylsulphonyl - (imino - imidazolidines) CIBA-GEIGY AG 3 Sept 1970 [4 Sept 1969] 42106/70 Heading C2C [Also in Division A5] Novel, therapeutic compounds I (including salts thereof) where R 1 is C 1 to C 6 alkyl, C 3 to C 5 alkenyl, C 5 to C 8 cyclo-alkyl or -alkenyl, or phenalkyl of up to 9 C, R 2 is H, Me or Et, R 3 is C 1 to C 6 alkyl, m is 2 or 3, n is 1 to 4, Y is O or S and Z is O, S, SO or SO 2 , are made by reacting II with R 3 .Z.C n H 2n C( :Y)OH or with a reactive, derivative thereof (including, e.g. dithiocarboxylic acid esters). Methoxydithioacetic acid benzyl ester is prepared by interacting hydrogen sulphide and methoxythioacetamido benzyl ester hydrochloride which is, in turn, prepared by interacting methoxyacetonitrile and benzylmercaptan in the presence of hydrogen chloride.
展开▼
机译:1306602酰基氨基和硫代酰基氨基烷基-苯磺酰基-(亚氨基-咪唑烷)CIBA-GEIGY AG 1970年9月3日[1969年9月4日]标题C2C [也在A5分部中]其中R 1是的新型治疗性化合物I(包括其盐) C 1至C 6烷基,C 3至C 5烯基,C 5至C 8环烷基或-烯基或苯烷基,最高至9 C,R 2为H,Me或Et,R 3为C 1至C 6烷基,m为2或3,n为1-4,Y为O或S,Z为O,S,SO或SO 2,是通过II与R 3反应制得的。ZC n H 2n C(:Y) OH或其具有反应性的衍生物(包括例如二硫代羧酸酯)。甲氧基二硫代乙酸苄基酯是通过使硫化氢与甲氧基硫代乙酰胺基苄基酯盐酸盐相互作用而制得的,而后者又是通过使甲氧基乙腈和苄基硫醇在氯化氢存在下相互作用而制得的。
展开▼